Contour+

AI in Prostate Cancer Radiotherapy Planning
Across much of the world, men are living into older age in greater numbers than ever before. With this increase in years comes a different…
Multi-Institutional Study Demonstrates Time and Consistency Benefits of MVision Contour+ for Head and Neck Radiotherapy
MVision Contour+ improves consistency and saves time, according to HARMONY, a multi-institutional international study. The research was conducted in seven clinics from four countries and…
Case Study: SLRON’s Integration of MVision AI in Radiotherapy Planning and Clinical Training
Overview St. Luke’s Radiation Oncology Network (SLRON) is Ireland’s largest radiotherapy provider and one of the largest centres in Europe. It treats over 5,500 patients…
MVision AI’s Contour+ Receives Market Approval in Morocco
Helsinki, June 2025 — MVision AI is pleased to announce that Contour+, its AI-powered auto-contouring software for radiation therapy, has received market approval for clinical…
MVision AI’s Contour+ Approved for Clinical Use in Singapore
Helsinki, May 2025 — MVision AI announces that Contour+, its AI-based auto-contouring software for radiation therapy, has received market approval for clinical use in Singapore.…
MVision AI’s Contour+ Receives Market Clearance in the United Arab Emirates
HELSINKI, Finland – April 2025 — Contour+, MVision AI’s AI-powered auto-contouring software, has received market clearance from the United Arab Emirates Ministry of Health and…
MVision AI’s Contour+ MR Models Achieve TGA Market Approval in Australia
Helsinki, Finland – February 2025 – The Therapeutic Goods Administration (TGA) of Australia has granted market approval for MVision AI’s MR-based segmentation models included in…